Filing Details
- Accession Number:
- 0001140361-21-013902
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-22 16:27:26
- Reporting Period:
- 2021-04-21
- Accepted Time:
- 2021-04-22 16:27:26
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
70318 | Tenet Healthcare Corp | THC | Services-General Medical & Surgical Hospitals, Nec (8062) | 952557091 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1138995 | Glenview Capital Management, Llc | 767 Fifth Avenue 44Th Floor New York NY 10153 | No | No | No | No | |
1228603 | Larry Robbins | 767 Fifth Avenue 44Th Floor New York NY 10153 | No | No | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock, $0.05 Par Value | Disposition | 2021-04-21 | 64,090 | $55.10 | 13,608,836 | No | 4 | S | Indirect | See footnotes |
Common Stock, $0.05 Par Value | Disposition | 2021-04-21 | 58,000 | $55.57 | 13,550,836 | No | 4 | S | Indirect | See footnotes |
Common Stock, $0.05 Par Value | Disposition | 2021-04-22 | 2,572,941 | $55.01 | 10,977,895 | No | 4 | S | Indirect | See footnotes |
Common Stock, $0.05 Par Value | Disposition | 2021-04-22 | 249,702 | $56.46 | 10,728,193 | No | 4 | S | Indirect | See footnotes |
Common Stock, $0.05 Par Value | Disposition | 2021-04-22 | 82,873 | $57.28 | 10,645,320 | No | 4 | S | Indirect | See footnotes |
Common Stock, $0.05 Par Value | Disposition | 2021-04-22 | 26,197 | $54.95 | 26,197 | No | 4 | S | Direct | |
Common Stock, $0.05 Par Value | Disposition | 2021-04-22 | 26,197 | $56.25 | 0 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Indirect | See footnotes |
No | 4 | S | Indirect | See footnotes |
No | 4 | S | Indirect | See footnotes |
No | 4 | S | Indirect | See footnotes |
No | 4 | S | Indirect | See footnotes |
No | 4 | S | Direct | |
No | 4 | S | Direct |
Footnotes
- These shares of the Issuer's Common Stock, $0.05 par value per share (the "Shares") were sold by Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC.
- This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 21, 2021 within a $1.00 range. The actual prices for these transactions range between $50.5554.305 to $51.342555.2929, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
- This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 21, 2021 within a $1.00 range. The actual prices for these transactions range between $55.535 to $55.60, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
- This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $56.045 to $57.04, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
- This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $57.045 to $57.665, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
- This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $54.87 to $54.99, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
- This price reflects the weighted average purchase price for open-market sales of Shares made by the Reporting Persons on April 22, 2021 within a $1.00 range. The actual prices for these transactions range between $56.22 to $56.42, inclusive. The Reporting Persons further undertake to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares sold at each separate price.
- These Shares are held for the accounts of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles managed by Glenview Capital Management, LLC. Glenview Capital Management, LLC serves as investment manager to each of Glenview Capital Partners, L.P., Glenview Capital Master Fund, Ltd., Glenview Institutional Partners, L.P., Glenview Offshore Opportunity Master Fund, Ltd., Glenview Capital Opportunity Fund, L.P., and certain other associated investment vehicles. Mr. Robbins is the Chief Executive Officer of Glenview Capital Management, LLC.
- Each Reporting Person disclaims beneficial ownership of the Shares except to the extent of his or its pecuniary interest therein, and this report shall not be deemed an admission that such Reporting Person is the beneficial owner of the Shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.